HERON CONNECT
Live / Registered — Registered (as of 10 Jul 2018)
What this means for you
Registered since 10 Jul 2018. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use was filed 28 Nov 2023 and is awaiting the USPTO's acceptance).
Record
- Serial number
- 87608962
- Registration number
- 5515457
- Mark type
- Word mark
- Filed
- 14 Sept 2017
- Published for opposition
- 30 Jan 2018
- Registered
- 10 Jul 2018
- Next maintenance filing
- §8 declaration of use, filed 28 Nov 2023 — awaiting the USPTO's acceptance
- Attorney of record
- Beth M. Goldman
Goods and services
- Class 036 — Insurance and financial services: Financial administration of health reimbursement arrangements; financial administration of patient reimbursement programs; assistance in collecting from pharmaceutical reimbursement programs for patients, pharmacists and physicians
Owner
- Heron Therapeutics, Inc., San Diego, CA, US
- Heron Therapeutics, Inc., San Diego, CA, US
- Heron Therapeutics, Inc., San Diego, CA, US
Prosecution history
- 28 Nov 2023 — TEAS SECTION 8 & 15 RECEIVED
- 16 Aug 2023 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 10 Jul 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 10 Jul 2018 — REGISTERED-PRINCIPAL REGISTER
- 06 Jun 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Jun 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 May 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 16 Apr 2018 — USE AMENDMENT FILED
- 04 May 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 16 Apr 2018 — TEAS STATEMENT OF USE RECEIVED
- 27 Mar 2018 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 30 Jan 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Jan 2018 — PUBLISHED FOR OPPOSITION
- 10 Jan 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Dec 2017 — APPROVED FOR PUB - PRINCIPAL REGISTER